ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Institutional investor · Portfolio as of Q4 2018
Top Holdings1,320 positions
VISA INC | 6M | $785.4M | 2.1% | $124.91 | 0.00% | 1 qtr | First report 0 |
HOME DEPOT INC | 4.6M | $782.7M | 2.1% | $141.60 | 0.00% | 1 qtr | First report 0 |
BRISTOL-MYERS SQUIBB CO | 14.8M | $767.5M | 2.0% | $38.81 | 0.00% | 1 qtr | First report 0 |
MASTERCARD INCORPORATED | 4M | $760.9M | 2.0% | $180.51 | 0.00% | 1 qtr | First report 0 |
ISHARES INC | 11.2M | $661.7M | 1.7% | $51.75 | 0.00% | 1 qtr | First report 0 |
ABBVIE INC | 7.1M | $658.6M | 1.7% | $66.47 | 0.00% | 1 qtr | First report 0 |
TJX COS INC NEW | 14.4M | $642.2M | 1.7% | $40.34 | 0.00% | 1 qtr | First report 0 |
MICROSOFT CORP | 5.7M | $583.5M | 1.5% | $94.43 | 0.00% | 1 qtr | First report 0 |
ADOBE INC | 2.5M | $569.3M | 1.5% | $226.24 | 0.00% | 1 qtr | First report 0 |
HCA HEALTHCARE INC | 4.1M | $506.6M | 1.3% | $116.44 | 0.00% | 1 qtr | First report 0 |
MERCK & CO INC | 6.1M | $466M | 1.2% | $57.51 | 0.00% | 1 qtr | First report 0 |
TAIWAN SEMICONDUCTOR MFG LTD | 12.6M | $463.3M | 1.2% | $31.32 | 0.00% | 1 qtr | First report 0 |
BIOGEN INC | 1.5M | $458.6M | 1.2% | $293.52 | 0.00% | 1 qtr | First report 0 |
ASTRAZENECA PLC | 11.7M | $444.6M | 1.2% | $61.50 | 0.00% | 1 qtr | First report 0 |
INTEL CORP | 9M | $423.9M | 1.1% | $40.23 | 0.00% | 1 qtr | First report 0 |
UNITEDHEALTH GROUP INC | 1.7M | $422.2M | 1.1% | $217.84 | 0.00% | 1 qtr | First report 0 |
SHIRE PLC | 2.4M | $417.1M | 1.1% | $173.00 | — | 1 qtr | First report 0 |
CELGENE CORP | 5.6M | $361.4M | 0.9% | — | — | 1 qtr | First report 0 |
AUTOMATIC DATA PROCESSING IN | 2.7M | $359.5M | 0.9% | $110.58 | 0.00% | 1 qtr | First report 0 |
INTERNATIONAL BUSINESS MACHS | 3.2M | $359.4M | 0.9% | $78.51 | 0.00% | 1 qtr | First report 0 |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP manages $38.2B across 1320 positions as of Q4 2018. Top holdings: V (2.1%), HD (2.1%), BMY (2.0%). Fund DNA: Diversified Scout. HoldingsIntel Score: 4/5.0.
First quarter we have for this fund: 1320 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $38.2B across 1320 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR